Cadila Healthcare

Cadila Fourth Quarter Net Profit Doubles to Rs. 131 crore

Cadila Fourth Quarter Net Profit Doubles to Rs. 131 crore

On Thursday, Pharma leader, Cadila Healthcare said that its consolidated net profit soared more than double to Rs. 131.05 crore for the fourth quarter that concluded March 31, over the same period corresponding financial.

Ahmedabad-based, Cadila Healthcare that is worth Rs. 3,550 crore, said in a filing to the Bombay Stock Exchange that overall sales and other revenue from operations swelled to Rs. 846.57 crore for the quarter that ended March
31, compared to Rs. 723.40 crore in the same period preceding financial year.

Cadila Healthcare gets approval from WHO for Rabies Vaccine

Cadila Healthcare, the flagship company of Zydus Cadila Group, has announced that it has got sanction from World Health Organization to market Lyssavac N- the Purified Duck Embroyo Rabies Vaccine (PDEV) to various United Nation Agencies. 

With this, the company has become the first Indian and the second pharmaceutical company in the world, to get approval from WHO.

Country’s largest maker of rabies vaccine, Zydus Cadila produces 3 million doses of the vaccine per annum. 

Cadila Healthcare gets nod for Bromocriptine Mesylate Capsules

The Ahmedabad-based pharmaceutical major, Cadila Healthcare Ltd (Zydus Cadila) has finally received an approval from the USFDA to market Bromocriptine Mesylate Capsules, 5 mg.

The drug falls in the women's healthcare segment and is also used as an adjunct therapy in the CNS segment.

The total sales figure for Bromocriptine Mesylate Capsules as per NDC was estimated at US$11.4million in 2007.

Stock Markets higher as FMCG and Technology Stocks trade higher

Pharmaceutical stocks were among major gainers in today's trading session. Cadila Healthcare was up by 3.6%. Biocon India was up by 3.4% at Rs 441. IPCA Labs was up by 3.3%. Multinational pharmaceutical majors Pfizer and Glaxo SmithKline Pharma were also up by almost 3%. Among losers in pharmaceutical space were Orchid Chemicals and Wockhardt Ltd.

Some select FMCG sector stocks were trading with decent gains. Godrej Consumer was up by 7.2%. GSK Consumer was up by 4.5%. Hindustan Lever was up by 2% at Rs 220.